Skip to main navigation

Investors
Contact

About
Investors
Investors
Shareholder Tools
Newsroom
Contact

Investor Information

AddThis Sharing Buttons

Share to LinkedIn Share to Facebook Share to Twitter

News Releases

Keyword Search

Year

August 7, 2019

Zomedica Announces TRUFORMA™ Assay Updates and R&D Expansion

July 25, 2019

Zomedica’s Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4

July 17, 2019

Zomedica Announces Initiation of a Digital Data Platform Enhancing its Diagnostic Pipeline

June 13, 2019

Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform

June 12, 2019

Zomedica to Present at Raymond James Life Sciences and MedTech Conference

June 10, 2019

Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares

May 21, 2019

Zomedica Announces Achievement of Product Development Milestones on its TRUFORMA™ Point-of-Care Diagnostic Platform

May 10, 2019

Zomedica Announces First Quarter 2019 Financial Results

May 10, 2019

Zomedica Announces Private Placement of Preferred Shares

March 26, 2019

Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares

Pagination

First page
Previous page
…
Page 3
Page 4
Page 5
Page 6
Current page 7
Page 8
Page 9
Page 10
Page 11
…
Next page
Last page

Investors

Investor Overview
News Releases
Events & Presentations
Stock Information
Financial Information
Corporate Governance
Investor FAQs
Email Alerts
Contact IR

Shareholder Tools

Email Alerts
RSS Feeds
Print Page
Share This

X

LinkedIn
Facebook
Twitter

OUR VISION & MISSION

Advancing the health, effectiveness, and financial well-being of the companion animal veterinarian by delivering economically and professionally beneficial products and services.

Zomedica on LinkedIn
Zomedica on Facebook
Zomedica on Youtube
Zomedica on Twitter

© 2021 Zomedica Corp. and Zomedica Inc. All Rights Reserved.

Privacy Notice
Terms of Use
Forward Looking Statements